Oruka Therapeutics Inc (ORKA) Hedge Fund Ownership (Q1 2026)

Oruka Therapeutics Inc (ORKA)

180 + Investors. Track Smart Money conviction in ORKA. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — ORKA

Based on 182 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 7 quarters in a row

last 6Q

For 7 consecutive quarters, more hedge funds added ORKA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

182 hedge funds hold ORKA right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +164% more funds vs a year ago

fund count last 6Q

+113 new funds entered over the past year (+164% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 70% buying

126 buying53 selling

Last quarter: 126 funds were net buyers (63 opened a brand new position + 63 added to an existing one). Only 53 were sellers (31 trimmed + 22 sold completely). A clear majority buying is a strong confirmation signal.

📈

More new buyers each quarter (+18 vs last Q)

new funds entering per quarter

Funds opening a new ORKA position: 26 → 32 → 45 → 63. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.

🔄

Mostly new holders — 62% entered in last year

■ 3% conviction (2yr+) ■ 35% medium ■ 62% new

Only 6 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Price up while funds trimmed (+61% value, -1% shares)

Value

+61%

Last quarter: total value of institutional ORKA holdings rose +61% even though funds reduced share count by 1%. The stock price increased enough to offset the selling. Institutions are quietly trimming into price strength — watch for rotation.

🚀

Acceleration phase — new buyers rushing in

16 → 26 → 32 → 45 → 63 new funds/Q

New funds entering each quarter: 26 → 32 → 45 → 63. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🌱

Early stage — 70% of holders entered in last year

■ 5% veterans ■ 25% 1-2yr ■ 70% new

Of 185 current holders: 130 (70%) entered in the past year, only 9 (5%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

✅

Strong quality — 35% AUM from major funds

35% from top-100 AUM funds

43 of 181 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

6.4

out of 10

Moderate Exit Risk

Exit risk score 6.4/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q1)	Prior (2025 Q4)	Change
Funds Holding	180	141	27.66%
13F Shares	52M	53M	-0.89%
Total Value	$2.55B	$1.58B	60.97%
New Positions	62	45	+17
Increased Positions	62	54	+8
Closed Positions	23	9	+14
Reduced Positions	30	17	+13
Total Calls	2	1	100.0%
Total Puts	2	1	100.0%
PUT/CALL Ratio	1.0	1.0	Neutral

Metric

All 13F Filers (2026 Q1)

Prior (2025 Q4)

Change

Funds Holding

180

141

27.66%

13F Shares

52M

53M

-0.89%

Total Value

$2.55B

$1.58B

60.97%

New Positions

+17

Increased Positions

Closed Positions

+14

Reduced Positions

+13

Total Calls

100.0%

Total Puts

100.0%

PUT/CALL Ratio

1.0

Neutral

Institutional Holders (2026 Q2)

180 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ORKA. Verified SEC 13F-HR filings.

QUARTER:

2026 Q2 filings are still coming in. Only funds that have filed so far are shown — top holders may not have reported yet. Full 13F data typically settles by ~50 days after quarter-end.

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 ORKA holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Remedium Capital Partners, LLC	32.99%	1,565,661	$149.0M
2	Fairmount Funds Management LLC	23.31%	3,705,262	$352.6M
3	Silverarc Capital Management, LLC	3.49%	352,802	$33.6M
4	B Group, Inc.	3.35%	75,000	$7.1M
5	Bellevue Group AG	3.32%	1,657,190	$157.7M
6	Synergy Asset Management, LLC	3.20%	356,301	$33.9M
7	Sectoral Asset Management Inc	2.79%	41,987	$4.0M
8	Deep Track Capital, LP	2.67%	1,926,000	$183.3M
9	Rtw Investments, LP	2.55%	3,139,030	$298.7M
10	Affinity Asset Advisors, LLC	2.54%	590,000	$56.2M
11	Stempoint Capital LP	1.91%	116,461	$11.1M
12	Moody Aldrich Partners LLC	1.73%	101,411	$9.7M
13	Atle Fund Management AB	1.41%	54,886	$5.2M
14	Parkman Healthcare Partners LLC	1.10%	113,188	$10.8M
15	Summit Partners Public Asset Management, LLC	1.10%	658,301	$62.7M
16	HighVista Strategies LLC	0.91%	41,902	$4.0M
17	Secure Asset Management, LLC	0.88%	65,899	$6.3M
18	Rhenman & Partners Asset Management AB	0.72%	80,000	$7.6M
19	Atika Capital Management LLC	0.63%	100,000	$9.5M
20	Artia Global Partners LP	0.59%	33,400	$3.2M
21	AlphaCentric Advisors LLC	0.53%	6,531	$622K
22	Informed Momentum Co LLC	0.50%	59,014	$5.6M
23	Siren, L.L.C.	0.48%	250,000	$23.8M
24	Ground Swell Capital, LLC	0.44%	4,320	$411K
25	Seven Grand Managers, LLC	0.42%	110,000	$10.5M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Oruka Therapeutics Inc (ORKA)

What does the Smart Money Trend signal show for ORKA?

Buying streak — 7 quarters in a row: For 7 consecutive quarters, more hedge funds added ORKA than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ORKA?

More buyers than sellers — 70% buying: Last quarter: 126 funds were net buyers (63 opened a brand new position + 63 added to an existing one). Only 53 were sellers (31 trimmed + 22 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ORKA holders?

Strong quality — 35% AUM from major funds: 43 of 181 holders rank in the top 100 by AUM, accounting for 35% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ORKA?

Mostly new holders — 62% entered in last year: Only 6 funds (3%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Oruka Therapeutics Inc (ORKA)

Smart Money Signals — ORKA

Buying streak — 7 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +164% more funds vs a year ago

More buyers than sellers — 70% buying

More new buyers each quarter (+18 vs last Q)

Mostly new holders — 62% entered in last year

Price up while funds trimmed (+61% value, -1% shares)

Acceleration phase — new buyers rushing in

Early stage — 70% of holders entered in last year

Strong quality — 35% AUM from major funds

Institutional Sentiment Summary — ORKA

Hedge Fund Ownership: ORKA

Market Analysis: ORKA

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: ORKA

Hedge Fund Positioning: ORKA

Statistics: ORKA

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Oruka Therapeutics Inc (ORKA)

Welcome to 13Foresight!